This targeted blend of lipotropic nutrients - Support steady fat metabolism and - Aid the liver in breaking down toxins and excess fat* - Promote mental clarity, focus, and balanced mood* - Enhance vitality, skin health, and overall resilience* The result: energy that lasts not just a lift
Because of this, certain groups may want to exercise caution or avoid these supplements altogether: People taking hormone-related or other prescription medications Ingredients in hormone-support supplements may interact with treatments such as hormone replacement therapy (HRT), birth control, diabetes medications, thyroid hormones, immunosuppressants, antihypertensives, sedatives, and others.35 These interactions can alter how medications work or increase the risk of side effects
A B12 injection bypasses the gut entirely
WADA Prohibition The World Anti-Doping Agency explicitly prohibits AOD-9604 for competitive athletes: Listed under Section S0 (Non-Approved Substances) and S2.2.3 (Growth Hormone Fragments) Prohibited at all times (both in-competition and out-of-competition) No Therapeutic Use Exemptions (TUEs) available Detection methods developed and implemented in anti-doping laboratories worldwide WADAs 2013 statement clarified that AOD-9604 is a substance still under pre-clinical and clinical development and has not been approved for therapeutic use by any government health authority in the world. Research Classification: AOD-9604 is available only for laboratory research use
Anticipated Costs Post-Approval While neither compound has reached market, pricing for similar medications provides context: Semaglutide (Wegovy) Approximately $1,300-$1,500 monthly without insurance Tirzepatide (Zepbound) Approximately $1,000-$1,200 monthly without insurance Cagrilintide and retatrutide would likely fall in similar price ranges, with combination therapy potentially costing $2,000-$3,000 monthly without insurance coverage
